These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 17588683

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. R278995/CRA0450, a corticotropin-releasing factor (CRF(1)) receptor antagonist modulates REM sleep measures in rats: Implication for therapeutic indication.
    Ahnaou A, Steckler T, Heylen A, Kennis L, Nakazato A, Chaki S, Drinkenburg WH.
    Eur J Pharmacol; 2012 Apr 05; 680(1-3):63-8. PubMed ID: 22314225
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pain is a salient "stressor" that is mediated by corticotropin-releasing factor-1 receptors.
    Hummel M, Cummons T, Lu P, Mark L, Harrison JE, Kennedy JD, Whiteside GT.
    Neuropharmacology; 2010 Sep 05; 59(3):160-6. PubMed ID: 20470804
    [Abstract] [Full Text] [Related]

  • 7. Peripheral and central administration of exogenous urocortin 1 disrupts the fasted motility pattern of the small intestine in rats via the corticotrophin releasing factor receptor 2 and a cholinergic mechanism.
    Yin Y, Dong L, Yin D.
    J Gastroenterol Hepatol; 2008 Jul 05; 23(7 Pt 2):e79-87. PubMed ID: 17944898
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of urocortin, corticotropin-releasing factor (CRF) receptor agonist, and astressin, CRF receptor antagonist, on the sleep-wake pattern: analysis by radiotelemetry in conscious rats.
    Uchida M, Suzuki M, Shimizu K.
    Biol Pharm Bull; 2007 Oct 05; 30(10):1895-7. PubMed ID: 17917258
    [Abstract] [Full Text] [Related]

  • 12. Cholinergic regulation of the central nucleus of the amygdala in rats: effects of local microinjections of cholinomimetics and cholinergic antagonists on arousal and sleep.
    Sanford LD, Yang L, Tang X, Dong E, Ross RJ, Morrison AR.
    Neuroscience; 2006 Sep 15; 141(4):2167-76. PubMed ID: 16843604
    [Abstract] [Full Text] [Related]

  • 13. Blockage of dopaminergic D(2) receptors produces decrease of REM but not of slow wave sleep in rats after REM sleep deprivation.
    Lima MM, Andersen ML, Reksidler AB, Silva A, Zager A, Zanata SM, Vital MA, Tufik S.
    Behav Brain Res; 2008 Apr 09; 188(2):406-11. PubMed ID: 18201777
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alleviation of the effects of endotoxin exposure on behavior and hippocampal IL-1beta by a selective non-peptide antagonist of corticotropin-releasing factor receptors.
    Kohman RA, Tarr AJ, Sparkman NL, Day CE, Paquet A, Akkaraju GR, Boehm GW.
    Brain Behav Immun; 2007 Aug 09; 21(6):824-35. PubMed ID: 17339098
    [Abstract] [Full Text] [Related]

  • 20. Neuromedin U(2) receptor signaling mediates alteration of sleep-wake architecture in rats.
    Ahnaou A, Drinkenburg WH.
    Neuropeptides; 2011 Apr 09; 45(2):165-74. PubMed ID: 21296417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.